Daily Anesthesiology Research Analysis
Today’s top anesthesiology research advances span precision hemodynamics, hemostasis monitoring, and perioperative efficiency. An RCT shows transcranial Doppler–guided norepinephrine titration reduces cerebral hypoperfusion episodes and improves GCS in sepsis-induced encephalopathy without changing ICU mortality. Mechanistic data reveal that viscoelastic testing clot times fail to detect PCC-augmented thrombin generation, challenging current transfusion triggers, while a large cohort quantifies
Summary
Today’s top anesthesiology research advances span precision hemodynamics, hemostasis monitoring, and perioperative efficiency. An RCT shows transcranial Doppler–guided norepinephrine titration reduces cerebral hypoperfusion episodes and improves GCS in sepsis-induced encephalopathy without changing ICU mortality. Mechanistic data reveal that viscoelastic testing clot times fail to detect PCC-augmented thrombin generation, challenging current transfusion triggers, while a large cohort quantifies the OR time and economic burden of prolonged extubation.
Research Themes
- Goal-directed hemodynamics using neuromonitoring
- Hemostatic monitoring and PCC decision-making
- Operating room efficiency and extubation timing
Selected Articles
1. Altered thrombin generation with prothrombin complex concentrate is not detected by viscoelastic testing: an in vitro study.
In an ex vivo study using blood from 13 healthy donors, thrombin generation increased after hemodilution and further after 4F-PCC spiking, but viscoelastic clot times (CT/ACT) on four platforms did not reflect this augmentation. Findings challenge algorithms that trigger PCC administration based on prolonged CT/ACT to enhance thrombin generation.
Impact: This work directly questions a widespread practice of using VET clot times as triggers for PCC in bleeding management, suggesting potential overtreatment or misguidance. It will likely recalibrate transfusion algorithms and prompt validation with outcome studies.
Clinical Implications: Avoid relying solely on prolonged CT/ACT to trigger PCC in bleeding/hemodilution; integrate thrombin generation or comprehensive coagulation assessment where feasible, and prioritize clinical context.
Key Findings
- Thrombin generation parameters (velocity index, peak, endogenous thrombin potential) increased after 50% dilution and further after 4F-PCC spiking (all P<0.01 to <0.001).
- Viscoelastic clot initiation times (CT/ACT) were prolonged by dilution on all four devices but did not improve after 4F-PCC spiking.
- Standard coagulation tests improved after PCC spiking but did not return to baseline.
Methodological Strengths
- Cross-platform assessment using four commercial viscoelastic devices enhances generalizability.
- Concurrent thrombin generation assays provide mechanistic validation beyond clot times.
Limitations
- In vitro ex vivo design in healthy donor blood limits clinical extrapolation.
- Sample size is modest (n=13) and lacks patient-centered outcomes.
Future Directions: Prospective clinical studies correlating thrombin generation, VET parameters, PCC dosing, and bleeding outcomes are needed to redefine PCC triggers.
BACKGROUND: Bleeding guidelines currently recommend use of viscoelastic testing (VET) to direct haemostatic resuscitation in severe haemorrhage. However, VET-derived parameters of clot initiation, such as clotting time (CT) and activated clotting time (ACT), might not adequately reflect a clinically relevant interaction of procoagulant and anticoagulant activity, as revealed by thrombin generation assays. The aim of this study was to evaluate the ability of CT and ACT to indicate thrombin generation activity. METHODS: Citrated whole blood obtained from 13 healthy volunteers underwent a 50% crystalloid dilution (DL-50%), followed by spiking with four-factor prothrombin complex concentrate (DL-50% + 4F-PCC). Changes in thrombin generation activity were compared with the VET parameters CT and ACT derived from four commercially available viscoelastic devices (ROTEM® Delta, ClotPro®, TEG®6s, and Quantra®) and standard coagulation tests. RESULTS: Dilution of whole blood resulted in a marked increase in velocity index, peak height, and endogenous thrombin potential (all P<0.01), with a further substantial increase after spiking with 4F-PCC (all P<0.001). In contrast, CT and ACT were significantly prolonged in response to DL-50% on all devices (all P<0.05). Subsequent spiking of diluted blood with 4F-PCC had no impact on CT and ACT derived from VET analysers, but it restored standard coagulation tests without reaching baseline values (all P<0.01). CONCLUSIONS: Upregulated thrombin generation parameters after PCC spiking were not displayed by CT, ACT, or standard tests. Our results do not support treatment algorithms using prolonged CT or ACT as a trigger for administration of PCC to augment thrombin generation.
2. Norepinephrine titration in patients with sepsis-induced encephalopathy: cerebral pulsatility index compared to mean arterial pressure guided protocol: randomized controlled trial.
In a single-center RCT of 112 SIE patients, TCD-PI–guided norepinephrine titration did not reduce ICU mortality versus SSC MAP ≥ 65 mmHg guidance, but it reduced episodes of cerebral hypoperfusion (CPP < 60 mmHg) and improved GCS at ICU discharge. Hemodynamic intensity (NE dose/duration), SOFA, lactate, and ICU LOS were similar between groups.
Impact: Introduces a neuromonitoring-guided vasopressor strategy with demonstrated physiologic and neurologic benefits, informing precision hemodynamics in sepsis care despite neutral mortality.
Clinical Implications: Consider TCD-based targets to minimize cerebral hypoperfusion in SIE when expertise and equipment are available; current data do not support mortality benefit, so use as an adjunct to SSC targets.
Key Findings
- No significant difference in ICU mortality between TCD-PI–guided and SSC MAP-guided groups (p=0.174).
- TCD-PI group had fewer cerebral hypoperfusion episodes (CPP < 60 mmHg; median 2; p=0.018).
- Higher MAP at end of NE infusion (mean 69.54 ± 10.42; p=0.002) and better GCS at ICU discharge (median 15; p=0.014) in the TCD-PI group.
Methodological Strengths
- Prospective randomized controlled design with trial registration (NCT05842616).
- Clear physiologic secondary endpoints (CPP, MAP, GCS) with invasive monitoring.
Limitations
- Single-center study with modest sample size (n=112).
- Open-label nature and no long-term neurologic outcomes reported.
Future Directions: Multicenter trials powered for clinical outcomes (mortality, long-term cognition) should evaluate TCD-guided hemodynamics and define patient subgroups who benefit most.
BACKGROUND: Although surviving sepsis campaign (SSC) guidelines are the standard for sepsis and septic shock management, outcomes are still unfavourable. Given that perfusion pressure in sepsis is heterogeneous among patients and within the same patient; we evaluated the impact of individualized hemodynamic management via the transcranial Doppler (TCD) pulsatility index (PI) on mortality and outcomes among sepsis-induced encephalopathy (SIE) patients.
METHODS: In this prospective, single-center randomized controlled study, 112 patients with SIE were randomly assigned. Mean arterial pressure (MAP) and norepinephrine (NE) titration were guided via the TCD pulsatility index to achieve a pulsatility index < 1.3 in Group I, whereas the SSC guidelines were used in Group II to achieve a MAP ≥ 65 mmHg. The primary outcome was intensive care unit (ICU) mortality and the secondary outcomes were; MAP that was measured invasively and values were recorded; daily in the morning, at the end of NE infusion and the end of ICU stay, duration of ICU stay, cerebral perfusion pressure (CPP), sequential organ failure assessment (SOFA) score, norepinephrine titration and Glasgow coma scale (GCS) score at discharge.
RESULTS: ICU mortality percentage wasnt significantly different between the two groups (p value 0.174). There was a significant increase in the MAP at the end of norepinephrine infusion (mean value of 69.54 ± 10.42 and p value 0.002) and in the GCS score at ICU discharge (Median value of 15 and p value 0.014) in the TCD group, and episodes of cerebral hypoperfusion with CPP < 60 mmHg, were significantly lower in the TCD group (median value of 2 and p value 0.018). Heart rate values, number of episodes of tachycardia or bradycardia, Total norepinephrine dosing, duration of norepinephrine infusion, SOFA score, serum lactate levels, and ICU stay duration werent significantly different between the two groups.
CONCLUSIONS: Individualizing hemodynamic management via the TCD pulsatility index in SIE patients was not associated with significant mortality reduction. However, it reduces episodes of cerebral hypoperfusion and improves GCS outcome but doesn't significantly affect heart rate values, SOFA score, serum lactate level, length of ICU stay, total NE dosing, and duration of NE infusion.
TRIAL REGISTRATION: The clinical trial was registered on clinucaltrials.gov under the identifier NCT05842616 https://clinicaltrials.gov/study/NCT05842616?cond=NCT05842616&rank=1 on 6-May-2023 before the enrolment of the first patient.
3. Economic impact of prolonged tracheal extubation times on operating room time overall and for subgroups of surgeons: a historical cohort study.
In a 12-year historical cohort of 182,374 cases, prolonged extubation (≥15 min) occurred in 23% and extended end-of-surgery–to–OR-exit time by a mean of 13.3 minutes (95% CI 12.8–13.7; P<0.0001). Effects were consistent across surgeon subgroups and were more frequent on days with >8 hours of cases, supporting treatment of added time as variable cost.
Impact: Quantifies the time and economic impact of prolonged extubation at scale, enabling targeted quality improvement and staffing/throughput strategies.
Clinical Implications: Prioritize extubation readiness and workflow to reduce delays, especially on high-utilization OR days; incorporate a ~13-minute variable cost estimate into scheduling and staffing models.
Key Findings
- Prolonged extubation occurred in 23% (41,768/182,374) of cases.
- Prolonged extubations added a mean 13.3 minutes to end-of-surgery–to–OR-exit time (95% CI 12.8–13.7; P<0.0001).
- Prolonged extubations predominantly occurred on days with >8 hours of cases (77% among surgeons with ≥9 prolonged extubations; P<0.0001).
Methodological Strengths
- Very large sample with surgeon-level pairwise comparisons and random-effects variance estimation.
- Consistent findings across multiple surgeon subgroup thresholds.
Limitations
- Single academic center; retrospective design limits causal inference.
- Operational cost estimates are context-specific and may vary across institutions.
Future Directions: Prospective QI interventions targeting extubation processes should assess impact on OR throughput, costs, and patient safety across diverse settings.
BACKGROUND: Prolonged tracheal extubation time is defined as an interval ≥ 15 min from the end of surgery to extubation. An earlier study showed that prolonged extubations had a mean 12.4 min longer time from the end of surgery to operating room (OR) exit. Prolonged extubations usually (57%) were observed during OR days with > 8 h of cases and turnovers, such that longer OR times from prolonged extubation can be treated as a variable cost (i.e., each added minute incurs an expense). The current study addressed limitations of the generalizability of these earlier investigations. METHODS: The retrospective cohort study included cases performed at a university hospital October 2011 through June 2023 with general anesthesia, tracheal intubation and extubation in the OR where the anesthetic was performed, and non-prone positioning. The primary endpoint was the interval from end of surgery to OR exit. Mean OR time differences with/without prolonged extubation were analyzed pairwise by surgeon. The variance among surgeons was estimated using the DerSimonian-Laird method with Knapp-Hartung adjustment for the sample sizes of surgeons. Proportions were analyzed after arcsine transformation, and the inverse taken to report results. RESULTS: There were prolonged extubations for 23% (41,768/182,374) of cases. Prolonged extubations had a mean 13.3 min longer time from the end of surgery to OR exit (95% confidence interval 12.8-13.7 min, P < 0.0001). That result was among the 71 surgeons each with ≥ 9 cases having prolonged extubation times and ≥ 9 cases with typical extubation times. Results were similar using a threshold of ≥ 3 cases, comprising 257 surgeons (13.2 min, P < 0.0001). Among the 71 surgeons with at least nine prolonged extubations, on most days with a prolonged extubation during at least one of their cases, there were > 8 h of cases and turnover times in the OR (77%, 73%-81%, P < 0.0001). Results were similar when analyzed for the 249 surgeons each with ≥ 3 cases with prolonged extubation (76%, P < 0.0001). CONCLUSIONS: Matching earlier findings, prolonged tracheal extubation times are important economically, increasing OR time by 13 min and usually performed in ORs with lists of cases of sufficient duration to treat the extra time as a variable cost.